These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8575586)

  • 1. Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor.
    Gatti E; Scagliotti GV; Ferrari G; Mutti L; Pozzi E; Stacchini A; Fubini L; Aglietta M
    Eur Respir J; 1995 Sep; 8(9):1566-71. PubMed ID: 8575586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma.
    Wislez M; Fleury-Feith J; Rabbe N; Moreau J; Cesari D; Milleron B; Mayaud C; Antoine M; Soler P; Cadranel J
    Am J Pathol; 2001 Oct; 159(4):1423-33. PubMed ID: 11583970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects.
    Hallsworth MP; Soh CP; Lane SJ; Arm JP; Lee TH
    Eur Respir J; 1994 Jun; 7(6):1096-102. PubMed ID: 7925879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha.
    Aloisi F; Carè A; Borsellino G; Gallo P; Rosa S; Bassani A; Cabibbo A; Testa U; Levi G; Peschle C
    J Immunol; 1992 Oct; 149(7):2358-66. PubMed ID: 1382099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
    Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
    Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
    Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
    Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumor necrosis factor-alpha and interleukin 1, downregulation by transforming growth factor beta and upregulation by fibroblast growth factor.
    Alsalameh S; Firestein GS; Oez S; Kurrle R; Kalden JR; Burmester GR
    J Rheumatol; 1994 Jun; 21(6):993-1002. PubMed ID: 7932447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha.
    Cromwell O; Hamid Q; Corrigan CJ; Barkans J; Meng Q; Collins PD; Kay AB
    Immunology; 1992 Nov; 77(3):330-7. PubMed ID: 1478679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1a+ and CD1a- accessory cells from human bronchoalveolar lavage differ in allostimulatory potential and cytokine production.
    van Haarst JM; Verhoeven GT; de Wit HJ; Hoogsteden HC; Debets R; Drexhage HA
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):752-9. PubMed ID: 8969270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carryover of cigarette smoke effects on hematopoietic cytokines to F1 mouse litters.
    Shukla M; Kumar P; Mishra V; Chaudhari BP; Munjal AK; Tripathi SS; Raisuddin S; Paul BN
    Mol Immunol; 2011 Sep; 48(15-16):1809-17. PubMed ID: 21636132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis.
    Ishioka S; Saito T; Hiyama K; Haruta Y; Maeda A; Hozawa S; Inamizu T; Yamakido M
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Sep; 13(2):139-45. PubMed ID: 8893383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
    de Gast GC; Klümpen HJ; Vyth-Dreese FA; Kersten MJ; Verra NC; Sein J; Batchelor D; Nooijen WJ; Schornagel JH
    Clin Cancer Res; 2000 Apr; 6(4):1267-72. PubMed ID: 10778950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
    Neta R; Oppenheim JJ; Douches SD
    J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
    Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
    J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.